News article relating to Imperial research
Sin títuloNews story relating to Imperial's work with the Somerset Otter Group.
Sin títuloStory confirming Thomson Environmental Consultants and Imperial College London's partnership
Sin títuloWebcapture from a recent training course (Nov 2020) held at the EBI (European Institute of Bioinformatics) that includes Phyre – open to academia and industry
Sin títuloPrint out of Google Analytics for access to Phyre
Sin títuloPress release from Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
Sin títuloPress release from Neuroprotexeon on the European Distribution Partnership between NeuroproteXeon and Linde
Sin títuloResults from the Phase 1 Trials - Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study
Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial
Phyre identified as a resource within ELIXIR UK node servies
Sin títuloCompanies House incorporation of Neuroprotexeon Limited
Sin títuloPhase 2 trials results
Information for Phase III Clinical Trials
Sin título